KieΔling, M. K., Nicolay, J. P., Schlör, T., Klemke, C., Süss, D., Krammer, P. H., & Gülow, K. (2017). NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib. Oncotarget.
Citação norma ChicagoKieΔling, Michael K., Jan P. Nicolay, Tabea Schlör, Claus-Detlev Klemke, Dorothee Süss, Peter H. Krammer, and Karsten Gülow. "NRAS Mutations in Cutaneous T Cell Lymphoma (CTCL) Sensitize Tumors Towards Treatment With the Multikinase Inhibitor Sorafenib." Oncotarget 2017.
Citação norma MLAKieΔling, Michael K., et al. "NRAS Mutations in Cutaneous T Cell Lymphoma (CTCL) Sensitize Tumors Towards Treatment With the Multikinase Inhibitor Sorafenib." Oncotarget 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.